Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Developments in anti-malaria agents: chemical data, structure-activity relationships].

M Debaert1

  • 1Pharmacie chimique - Chimie thérapeutique UFR de Pharmacie 3, rue du Professeur-Laguesse F 59045 Lille Cedex, France.

Annales Pharmaceutiques Francaises
|April 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of new N-substituted pyrrolidin-2-ones as cyclic analog of gamma-aminobutyric acid.

Annales pharmaceutiques francaises·2001
Same author

A multicentric comparison of transabdominal versus totally extraperitoneal laparoscopic hernia repair using PARIETEX meshes.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2000
Same author

Isomers of substituted 3-benzo[b]furyl and 3-thienylaminobutyric acids as potent ligands of the GABA-B receptor: synthesis and preparative liquid chromatographic separation.

Therapie·2000
Same author

GABAB receptor antagonism by resolved (R)-saclofen in the guinea-pig ileum.

European journal of pharmacology·1996
Same author

Structure-affinity relationships of baclofen and 3-heteroaromatic analogues.

Bioorganic & medicinal chemistry·1995
Same author

Thienyl-GABA derivatives as specific baclofen agonists in the rat and cat spinal cord in vivo.

Neuroscience letters·1993

This study reviews antimalarial drug evolution, focusing on artemisinin

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background:

  • Antimalarial drugs are crucial in combating malaria.
  • Evolution of drug resistance necessitates novel therapeutic strategies.
  • Understanding drug mechanisms aids in developing new treatments.

Purpose of the Study:

  • To describe the evolution of key antimalarial drugs.
  • To detail the mechanism of action of artemisinin and its metabolites.
  • To explore structure-activity and structure-neurotoxicity relationships.

Main Methods:

  • Literature review of antimalarial drug development.
  • Analysis of artemisinin's mechanism of action and metabolite formation.
  • Examination of structure-activity and structure-neurotoxicity data.

Related Experiment Videos

  • Review of synthetic methods for cyclic peroxyacetals.

    • Main Results:

    • Evolutionary pathways of amodiaquine, DHFR inhibitors, and artemisinin discussed.
    • Artemisinin's mechanism involves key metabolites influencing drug design.
    • Structure-activity and neurotoxicity relationships identified for certain compounds.
    • Examples of cyclic peroxyacetal synthesis provided.

    Conclusions:

    • Novel antimalarial compounds are emerging.
    • Understanding past drug evolution informs future drug design.
    • Continued research into structure-activity relationships is vital for effective antimalarials.